atrial fibrillation
Conditions
Interventions
None listed
Sponsors
The Japanese Society of Electrocardiology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: all patient with atrial fibrillation enrolled to J-RHYTHM Registry who accepted the informal consent
Exclusion criteria
Exclusion criteria: inadequate patients judged by their physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigation of clinical background at the development of following clinical event; symptomatic cerebral infarction, systemic embolism, major bleeding, all cause of death | — |
Secondary
| Measure | Time frame |
|---|---|
| Preventive effects of various medications including warfarin, antithrombotics drugs and others for the treatment of Japanese patients with atrial fibrillation | — |
Countries
Japan
Contacts
Public ContactHirotsugu Atarashi
Nippon Medical School Tama-Nagayama Hospital Internal Medicine
Outcome results
None listed